These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8148002)

  • 21. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets.
    Pulcinelli FM; Pignatelli P; Riondino S; Parisi S; Castiglioni C; Gazzaniga PP
    Thromb Res; 1994 Jun; 74(5):453-61. PubMed ID: 8085246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
    Sanderson HM; Heptinstall S; Vickers J; Lösche W
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):245-8. PubMed ID: 8735830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation.
    Soslau G; Youngprapakorn D
    Biochim Biophys Acta; 1997 Feb; 1355(2):131-40. PubMed ID: 9042333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
    Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG
    Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
    Ding YA; Chou TC; Chern JW; Yen MH
    Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
    Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
    Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitisation in human and rabbit blood platelets.
    Hallam TJ; Ruggles PA; Scrutton MC; Wallis RB
    Thromb Haemost; 1982 Jun; 47(3):278-84. PubMed ID: 7112500
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic profiles of vapiprost, a selective, long-lasting thromboxane receptor antagonist, after single and multiple oral administration to healthy volunteers.
    Uematsu T; Nagashima S; Mizuno A; Hirano K; Nakashima M
    J Clin Pharmacol; 1991 Sep; 31(9):815-22. PubMed ID: 1839540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of food intake on pharmacokinetics and effects of a new thromboxane A2 receptor antagonist, S-1452.
    Fujimura A; Shiga T; Kumagai Y; Ohashi K; Ebihara A; Kotegawa T
    Eur J Clin Pharmacol; 1996; 50(4):311-4. PubMed ID: 8803525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitroprusside inhibits platelet function primarily by inhibiting Ca2+ mobilization.
    Krishnamurthi S; Wheeler-Jones CP; Patel Y; Sadowska K; Kakkar VV; Rao GH
    Biochem Soc Trans; 1990 Jun; 18(3):468-9. PubMed ID: 2115470
    [No Abstract]   [Full Text] [Related]  

  • 35. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
    Turini ME; Holub BJ
    Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of thrombotic arterial occlusion following cholesterol feeding in the guinea-pig: a role for thromboxane A2.
    Hirata Y; Umemura K; Nakano M; Uematsu T; Nakashima M
    Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):81-6. PubMed ID: 7972270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
    Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
    Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
    Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
    Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.